Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Inventory (2016 - 2025)

Phibro Animal Health (PAHC) has 12 years of Inventory data on record, last reported at $471.8 million in Q3 2025.

  • For Q3 2025, Inventory changed N/A year-over-year to $471.8 million; the TTM value through Sep 2025 reached $471.8 million, changed N/A, while the annual FY2025 figure was $444.4 million, 67.13% up from the prior year.
  • Inventory reached $471.8 million in Q3 2025 per PAHC's latest filing, up from $444.4 million in the prior quarter.
  • Across five years, Inventory topped out at $471.8 million in Q3 2025 and bottomed at $206.3 million in Q1 2021.
  • Average Inventory over 4 years is $299.6 million, with a median of $259.2 million recorded in 2022.
  • Peak YoY movement for Inventory: grew 7.51% in 2021, then skyrocketed 67.13% in 2025.
  • A 4-year view of Inventory shows it stood at $230.8 million in 2021, then grew by 21.69% to $280.8 million in 2022, then fell by 5.32% to $265.9 million in 2024, then soared by 77.42% to $471.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $471.8 million in Q3 2025, $444.4 million in Q2 2025, and $448.4 million in Q1 2025.